z-logo
open-access-imgOpen Access
Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner
Author(s) -
Jiin-Tarng Liou,
Chih-Chieh Mao,
Fu-Chao Liu,
Huan-Tang Lin,
LiMan Hung,
ChangHui Liao,
YuanJi Day
Publication year - 2012
Publication title -
acta anaesthesiologica taiwanica
Language(s) - English
Resource type - Journals
eISSN - 1875-4597
pISSN - 1875-452X
DOI - 10.1016/j.aat.2012.07.001
Subject(s) - platelet , levobupivacaine , medicine , pharmacology , platelet activation , thromboxane a2 , protein kinase b , signal transduction , chemistry , biochemistry , bupivacaine
Levobupivacaine, an amide local anesthetic widely used in regional anesthesia, is reported in recent studies that it is a potent inhibitor of platelet functions. However, the concentrations of levobupivacaine were limitedly estimated in these reports. Additionally, the mechanisms by which it affects platelet function and blood coagulation is still not entirely known. The purpose of this study was to further investigate its effects on platelet function and the possible signaling mechanisms under various concentrations of levobupivacaine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom